AZAPROPAZONE IN THE TREATMENT OF ANKYLOSING SPONDYLITIS: A CONTROLLED CLINICAL TRIAL
- 1 February 1974
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 13 (1) , 23-29
- https://doi.org/10.1093/rheumatology/13.1.23
Abstract
In a controlled clinical trial the effect of azapropazone (900 mg. daily) was compared with placebo in 18 out-patients with ankylosing spondylitis. The trial was of “crossover” design, and results suggest that azapropazone may be of value in the symptomatic management of ankylosing spondylitis. The side-effects of the drug were mild and occurred with similar frequency during both drug and placebo periods.Keywords
This publication has 0 references indexed in Scilit: